| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |